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ABSTRACT: Toxicokinetic interactions with catabolic cytochrome P450 (CYP) enzymes
can inhibit chemical elimination pathways and cause synergistic mixture effects. We have
created a mathematical bottom-up model for a synergistic mixture effect where we fit a
multidimensional function to a given data set using an auxiliary nonadditive approach. The
toxicokinetic model is based on the data from a previous study on a fish cell line, where the
CYP1A enzyme activity was measured over time after exposure to various combinations of the
aromatic hydrocarbon β-naphthoflavone and the azole nocodazole. To describe the
toxicokinetic mechanism in this pathway and how that affects the CYP1A biomarker, the
model uses ordinary differential equations. Local sensitivity and identifiability analyses
revealed that all the 10 parameters estimated in the model were identified uniquely while
fitting the model to the data for measuring the CYP1A enzyme activity. The model has a good
prediction power and is a promising tool to test the synergistic toxicokinetic interactions
between different chemicals.
1. INTRODUCTION
Induction of cytochrome P450 1A (CYP1A) in fish can be
used as a biomarker to assess exposure to aromatic
hydrocarbons in aquatic environments. Induction of CYP1A
is typically measured as increased levels of transcription (i.e.,
CYP1A mRNA/CYP1A protein levels), increased CYP1A
enzyme activities, or a combination of both. Aromatic
hydrocarbons activate the aryl hydrocarbon receptor (AhR),
which results in induction of CYP1A synthesis. The AhR-
CYP1A signaling is central in the chemical detoxification
pathway in fish.1 The aquatic environment is also contami-
nated with other anthropogenic chemicals, including pharma-
ceuticals.2,3 Some pharmaceuticals can interfere with the AhR-
CYP1A signaling pathway. Hence, fish populations in their
natural habitats are exposed to mixtures of chemicals that can
interact with the AhR-CYP1A signaling and thereby affect the
CYP1A biomarker.4
The mixture effect of different chemicals is called an additive
effect if there is no direct interaction between the chemicals
when they exert their effects. Thus, the chemicals act
independently of each other with similar modes of action
(MoA) and the mixture effect can be explained by addition. If
a mixture gives an effect higher than the additive prediction,
this effect is called synergistic.5 There are established models to
assess additive mixture effects such as the concentration
addition, the independent action, and the generalized
concentration addition models.6 There are also models that
can identify nonadditive mixture effects from response patterns
for end points.7−10 These models are, however, empirical
models and lack a mechanistic basis for prediction. For this
reason, there is a need for models to assess nonadditive
mixture effects in a mechanistic manner, for example, to
describe synergistic effects in fish and other vertebrates.
Chemicals with the same or different MoA can interact with
each other’s detoxification mechanisms and cause adverse
toxicokinetic interactions. The value of integrating toxicoki-
netics, for a better mechanistic understanding to predict
interactions between different chemicals in mixtures, has been
advocated by the European Commission.11 A promising
approach, using a mechanistic toxicokinetic and toxicodynamic
model, was suggested to describe the synergistic mixture effects
between azole fungicides and a pyrethroid insecticide in the
invertebrate Daphnia magna. This model was based on the fact
that the synergistic potential of adding azoles could be
explained by the azoles occupying the CYP enzymes, which
reduces the biotransformation of the insecticide.12
Azoles [e.g., clotrimazole, ketoconazole, nocodazole (NOC),
omeprazole, prochloraz, and propiconazole] have been shown
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to interact with the CYP system in fish and fish cells.13−21
Most azoles act as potent inhibitors of CYP1A enzyme
activities but weak inducers of CYP1A transcription in
fish.17−19 Previous studies on the Poeciliopsis lucida hepatocel-
lular carcinoma (PLHC-1) cell line show that the benzimida-
zole and microtubule disassembling drug NOC alone acted as
Figure 1. Illustration of the pathway that the model describes. Chemical X (BNF, black triangles) and chemical Y (NOC, black squares) belong to
different chemical classes, each with different MoA. Induction of cytochrome P450 1A (CYP1A) is mediated via ligand activation of AhR. Chemical
X is a strong ligand to AhR (illustrated by a thick green arrow), which results in strong induction of CYP1A. Chemical Y is a weak ligand to AhR
(illustrated by a thin green arrow), which results in low induction of CYP1A. Both X and Y bind to the CYP1A enzymes, where X is metabolized by
CYP1A enzymes (blue arrow) and Y inhibits CYP1A enzymes (red arrow). Thus, chemical Y occupies the CYP1A enzymes in the elimination
pathway (the gray funnel shape), delaying biotransformation of chemical X, which in turn results in increased biological half-life of chemical X. This
toxicokinetic interaction between X and Y results in a synergistic mixture effect. The conceptual model, presented in this study, describes the
toxicokinetic interaction between chemicals X and Y in this pathway.
Table 1. Model Parameters and Their Descriptionsa
description unit value
State Variables
X concentrations of unbound BNF molecules μM
Y concentrations of unbound NOC molecules μM
Ef concentrations of free CYP1A enzymes (not used in model equations) μM
Ef
EROD EROD activity of free CYP1A enzymes pmol·(min·mg)−1
EOX concentrations of CYP1A enzymes occupied by BNF μM
EOY concentrations of CYP1A enzymes occupied by NOC μM
t time h
Initial Values
initial concentration of BNF μM 0.1 and 1
initial concentration of NOC μM 0, 1, 10, and 25
initial EROD activity of free CYP1A enzymes pmol·(min·mg)−1 0
initial concentration of CYP1A enzymes occupied by BNF μM 0
initial concentration of CYP1A enzymes occupied by NOC μM 0
Fixed parameters
γ proportionality constant between EROD activity and concentration of free CYP1A min·mg·L−1 1
n Hill coefficient 4
Estimated parameters
kX turnover number of the CYP1A enzyme for BNF (μM·h)−1 0.033 ± 0.010
kY turnover number of the CYP1A enzyme for NOC (μM·h)−1 0.039 ± 0.009
ki IC50 for NOC on EROD activity μM 1.37 ± 0.049
cX minimum concentration of BNF to induce EROD activity μM 0.063 ± 0.008
cY minimum concentration of NOC to induce EROD activity μM 0.542 ± 0.061
kAX rate of number of CYP1A enzymes induced by BNF h
−1 (μM)1/2 1.339 ± 0.060
kAY rate of number of CYP1A enzymes induced by NOC h
−1 0.252 ± 0.050
kOX rate of biotransformation of BNF molecules h
−1 0.375 ± 0.059
kOY rate of biotransformation of NOC molecules h
−1 0.060 ± 0.012
kD rate of CYP1A enzyme degradation h
−1 0.043 ± 0.003
aThe state variables are defined by eqs 4, 5, and 9−13. The initial values of the state variables are the different doses added to the cell cultures. The
model parameters are either fixed or estimated. The estimated parameters are given as the parameter estimate ± standard error. The parameters in
the model are fitted to experimental EROD data from a previous study where the cells were exposed to different mixtures of BNF and NOC in a
time course study (Table S1).21,22
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a potent inhibitor of the CYP1A enzyme activity and a weak
inducer of CYP1A expression. Compared to β-naphthoflavone
(BNF), NOC is 1 order of magnitude less potent and about 50
times less efficient to induce CYP1A expression.20,21 However,
a synergistic mixture effect with NOC and the prototypical
AhR agonist, BNF, was seen as increased induction of
CYP1A.21 Although BNF and NOC have different MoA,
they seem to share a common elimination pathway. Thus,
PLHC-1 cells exposed to NOC were more sensitive to BNF
exposures compared to cells exposed to BNF alone.21 The
synergistic mixture effect is based on the hypothesis that NOC
occupies the CYP1A enzymes, inhibiting the CYP1A-depend-
ent metabolism of BNF, which in turn enhances the BNF-
mediated AhR-CYP1A signaling (Figure 1).
The aim of this study was to create a new conceptual
toxicokinetic model to describe the toxicokinetic interaction
between BNF and NOC, where the dominant effect of NOC is
direct inhibition of CYP1A enzymes and the dominant effect of
BNF is induction of CYP1A transcription via activation of
AhR. This is a first attempt to create a mathematical bottom-
up model for synergistic mixture effects where we fit a
multidimensional function to a given experimental data set
from a previous study using an auxiliary nonadditive
model.21,22 The time dynamics is a key factor in the
toxicokinetic interactions. We hypothesized that by construct-
ing a model using ordinary differential equations (ODEs), we
can describe how the concentrations of the chemicals change
over time and their resulting effect on the CYP1A biomarker.
2. METHODS
2.1. Development of the Mathematical Model. To
describe the mixture effect on the CYP1A biomarker, we
construct a model using a set of ODEs. The model also
explains the individual effects of each chemical by setting the
initial concentrations of the other compounds equal to zero.
There are five concentration state variables in the equations,
where X represents the unbound BNF, Y represents the
unbound NOC, Ef represents the free CYP1A enzymes, EOX
represents the CYP1A enzymes occupied by BNF, and EOY
represents the CYP1A enzymes occupied by NOC. The state
variables, their initial values, and the parameters in the model
(i.e., constants) are listed with units in Table 1.
The rate by which the unbound BNF (X) is biotransformed
is modeled as















In this equation, the change in the number of unbound BNF
(X) molecules over time is described as a function of the
turnover number of the CYP1A enzyme for biotransformation
of BNF (kX) together with the number of molecules for free
CYP1A enzymes (Ef), BNF (X), and NOC (Y). The time unit
(t) is hours. A Hill function is used to describe that BNF and
NOC molecules compete for binding to the free CYP1A
enzymes. Consequently, the change in numbers of unbound
BNF molecules is affected by the number of NOC molecules
over time, which creates a delay in the BNF elimination
pathway. The parameters ki and n in the Hill function describe
the competition between the BNF and NOC molecules for the
free CYP1A enzymes. The parameter ki is the concentration of
NOC occupying half of the binding sites of the CYP1A
enzymes.
The change in the number of unbound NOC (Y) molecules
over time is described by second-order kinetics using the
turnover number of the CYP1A enzyme for biotransformation
of NOC (kY), number of molecules for free CYP1A enzymes
(Ef), and NOC (Y) giving
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The change in numbers of free CYP1A enzymes (Ef) over
time depends on the number of BNF (X) and NOC (Y)
molecules that are occupying the CYP1A enzymes. Hence,
binding of BNF and NOC molecules to the CYP1A enzymes
results in increased number of occupied CYP1A enzymes (EOX
and EOY) and decreased number of free CYP1A enzymes with
the degradation rate constant kD. The rate of change of free
CYP1A enzymes is modeled as
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The parameters kOX and kOY are the biotransformation rate
constants of BNF and NOC molecules, whereas the functions
f(X) and g(Y) describe the activation of the AhR-CYP1A
signaling by BNF and NOC, respectively.
The activation of AhR is controlled by the number of BNF
(X) and NOC (Y) molecules in the cells, in particular, the
number of BNF molecules. This is because BNF is more than
50 times more effective and around 10 times more potent
compared to NOC in activating the AhR-CYP1A signaling.20,22
The functions f(X) and g(Y) are therefore included to describe
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The values of cX and cY are the respective threshold
concentrations of BNF and NOC required to activate AhR-
CYP1A. Equivalently, the parameters kAX and kAY describe the
rates of BNF-induced and NOC-induced CYP1A enzymes,
respectively.
The rate of change for occupied CYP1A enzymes by BNF
(EOX) and NOC (EOY) are modeled as


















X f OX OX
(6)
= · · − ·
E t
t
k E t Y t k E t
d ( )
d
( ) ( ) ( )OY Y f OY OY (7)
The BNF and NOC molecules that occupy CYP1A enzymes
are being biotransformed by the CYP1A enzymes. Next, their
metabolites are released from the CYP1A enzymes and the
previously occupied CYP1A enzymes (EOX and EOY) become
free. The biotransformation rate constants are kOX and kOY.
The number of free CYP1A enzymes (Ef) consequently
increases and are available for the next cycle of biotransforma-
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tion. The CYP1A biotransformation reduces the numbers of
BNF and NOC molecules, and when there are too few
molecules to activate AhR, no more free CYP1A enzymes are
being synthesized. The remaining CYP1A will be degraded and
the numbers of Ef will decrease.
The measured data for the free CYP1A enzymes is the
diagnostic ethoxyresorufin-O-deethylase (EROD) activity that
is assumed to be proportional to the concentration of free
CYP1A enzymes. This assumption is justified by the fact that
only free CYP1A enzymes can carry out the EROD activity.
For this reason, we express the concentration of the free
CYP1A enzymes as
γ= ·E t E t( ) ( )f f
EROD
(8)
The parameter γ is a proportionality constant and Ef
EROD(t)
is the EROD activity of the free enzymes that can be measured.
The model equations then become
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Hence, we model the EROD activity that can be compared
with the data.21,22 Equation 11 is the rate of change in the
EROD activity of free CYP1A enzymes (Ef
EROD) over time.
Note that the two functions f(X) and g(Y) have not been
changed and are given by eqs 4 and 5.
2.2. Experimental Data Used. The PLHC-1 is an
established cell line used in aquatic toxicology and suggested
as an useful tool for mechanistic studies of regulation and
function of CYP1A.23,24 So far, only one CYP1A immunor-
eactive protein has been detected in PLHC-1 cells treated with
BNF.25 In addition, a partial CYP1A cDNA sequence was
isolated from BNF-treated PLHC-1 cells.20 The data used to
estimate the parameters in the model were obtained from a
previous study using PLHC-1 cells that had been treated with
the carrier vehicle and different doses of BNF (0.1 and 1 μM)
and NOC (1, 10, and 25 μM), alone or mixed together, and
measured at five different times (6, 12, 24, 48, and 72 h).21,22
The CYP1A-mediated EROD activities were analyzed in that
study.21,22 Data from four biological replicates (i.e., four
separate experiments each of which representing the mean of
four technical replicates) were used during the parameter
estimation.22 The raw data used to parameterize and validate
the model are given in Table S1. The effects of BNF and NOC
differ with BNF 10 times more potent and 50 times more
effective compared to NOC for activation of the AhR-CYP1A
signaling.20,22 However, the impact of NOC is still significant
because the concentration of NOC added to the cells are up to
250 times higher than for BNF and NOC is a potent inhibitor
of the CYP1A activity.21,22
2.3. Parameter Estimation. The model was implemented
using the R software.26 The model has two parameters (n and
γ) that were fixed before the estimation procedure. The
parameter n is the Hill coefficient and represents the inhibition
of the BNF biotransformation by the NOC molecules. We
proposed a set {2, 3, 4, 6, 10} of possible values for n and
performed the estimation procedure for each of them. Based
on this, the value of n was set to 4 because that made the
remaining parameters best able to fit the data. The
proportionality constant γ in eq 8 was set to 1 min·mg·L−1.
The remaining 10 parameters to be estimated are denoted by
the vector
= [ ]p k k k c c k k k k kiX Y X Y AX AY OX OY D T
The initial values for the concentrations of BNF (X) and
NOC (Y) were set to the concentrations that the cells have
been dosed with at t = 0. For each of the six treatments used to
develop the model, the initial values of the state variables were
therefore set to
To estimate the parameters in the model, the EROD data at
the five time points for the one single treatment and the five
different mixture treatments have been used. To compare the
simulated EROD activity of free CYP1A enzymes from the
model against its observations, we define a cost function,
cost(p), as27






















Equation 15 is the sum of squares of the logarithmic
residuals of the EROD activity of free CYP1A enzymes from
the model (Ef,model
EROD ) versus its experimental value (Ef,experiment
EROD ),
represented by EROD data. It should be noted that in the cost
function, one is added to the values of Ef,model
EROD and Ef,experiment
EROD to
avoid numerical instability. We summed over six treatments
with four biological replicates at five time points. The
estimated values for the parameters in p are those that
minimize cost(p). The modFit function from the flexible
modeling environment (FME) package in R28 was used to
perform the box constraint optimization. This method is
appropriate to use because of non-negativity constraints on the
parameters. The parameters in the model (i.e., constants) and
their fixed or fitted values are listed in Table 1.
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2.4. Global Sensitivity Analysis. Global sensitivity
analysis (GSA) is a tool to describe how the uncertainty in
the model parameters can influence the uncertainty in the
model output.29 GSA was performed to provide an overview of
the sensitivity of the EROD activity of free CYP1A enzymes to
uncertainty in the parameter values. GSA identifies the most
influential parameters on the model output and identifies
parameters that the model output is insensitive to.
The global sensitivity of the EROD activity of free CYP1A
enzymes to changes in each parameter (Table 1) was analyzed
using experimental EROD data.21,22 The GSA was performed
using the senseRange function from the FME package in R.28
For each of the parameters, a random sample of 1000 values
was drawn using a log-uniform distribution on the interval
from the estimated value divided by 10 to the estimated value
multiplied by 10. By using this distribution, the expected
number of values in the sample below and above the estimated
value will be equal.
Next, the global sensitivity of the EROD activity of free
CYP1A enzymes was estimated by varying one parameter at
the time using the sample described above and fixing the
remained parameters at their nominal values. The five coupled
ODEs in eqs 9−13 were solved numerically using the ode
function from the deSolve package in R.30 This was carried out
to calculate the EROD activity of free CYP1A enzymes over
time for each parameter set and for each of the six different
treatments represented in eq 14.
2.5. Local Sensitivity Analysis. A parameter is practically
nonidentifiable if it is not possible to determine a unique value
for it through fitting the model to the data. The two main
sources of practical nonidentifiability were analyzed: (1) lack
of influence of a parameter on the EROD activity of free
CYP1A enzymes (Ef
EROD) as the measurable model output and
(2) interdependence among the parameters.31
The local sensitivity analysis (LSA) was performed to assess
the sensitivity of the EROD activity of free CYP1A enzymes
(Ef
EROD), as the measurable model output, with respect to small
changes in the estimated parameters (Table 1). The sensitivity
of the EROD activity of free enzymes to change in the
parameter pl, while all other parameters were fixed at their













The sensitivity values were estimated numerically using the
sensFun function from the FME package in R.28 The
parameter value pl was perturbed by 1%. In order to take
into account the changes in time and across experiments, the
















This was summed over all five time points for each EROD
data in the six different treatment experiments, that is, n = 30.
The collinearities for all combinations of the 10 parameters in
p were tested using the Collin function from the FME package
in R.28
3. RESULTS AND DISCUSSION
The aim of the present study was to provide a new
mathematical bottom-up model to describe the synergistic
mixture effect between two different classes of chemicals on a
mechanistic level. Experimental data on CYP1A biomarker
responses in PLHC-1 exposed to BNF and NOC alone or in
binary mixtures were used. The model successfully predicts the
changes in CYP1A-mediated EROD activities of free CYP1A
enzymes over time by fitting the model to experimental EROD
data. In addition, 10 parameters could be estimated in the
model.
Figure 2. Fitted values for EROD activity of free CYP1A enzymes. The solid lines depict the EROD activity of free CYP1A enzymes from the
model fitted to the experimental EROD data [pmol·(min·mg protein)−1] (Table S1). The model is described by eqs 4, 5 and 9−13 and the
parameters are listed in Table 1. The circles, triangles, squares, and rhombuses represent EROD data from six independent experiments where the
cells are exposed to: (A) Treatment (1) 0.1 μM BNF (orange squares), Treatment (2) 0.1 μM BNF + 1 μM NOC (brown rhombuses), Treatment
(3) 0.1 μM BNF + 10 μMNOC (pink circles), and Treatment (4) 0.1 μM BNF + 25 μMNOC (blue triangles) and (B) Treatment (5) 1 μM BNF
+ 1 μMNOC (purple squares) and Treatment (6) 1 μM BNF + 25 μM NOC (green rhombuses). In all treatments, the EROD activities have been
measured at five different time points from 6 to 72 h.21,22 All experimental data are provided in Table S1.
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3.1. Model Predictions. The parameters in the model
were first estimated using the EROD data from six different
treatment experiments.21,22 The fitted values for the EROD
activity of free CYP1A enzymes from the model are shown in
Figure 2. The optimal value of cost function in eq 15 was equal
to 13.63. This value corresponds to the mean value of the
fraction (Ef,model
EROD + 1)/(Ef,experiment
EROD + 1) equals to 1.05, which is
good because it is close to a value of 1.00 that corresponds to a
perfect fit.
The fitted values for the number of free CYP1A enzymes in
cells cotreated with 1, 10, or 25 μM NOC, together with either
0.1 or 1 μM BNF, were in good agreement with the
experimental data (Figure 2A,B). In addition, there is a
satisfactory agreement between the fits for the number of free
CYP1A enzymes over time in cells treated with 0.1 μM BNF
alone and the experimental data21,22 (Figure 2A). Because no
significant induction of CYP1A activities could be measured in
cells treated with 1, 10, or 25 μM NOC alone (Table S3),
compared to that in vehicle control cells, no comparison with
fitted values was made for those treatments.
The model predicts the four concentration state variables, X,
Y, EOX, and EOY, over time (Figure 3). The model shows that
increasing the concentration of NOC (at t = 0) from 1 to 10 or
25 μM results in slower BNF biotransformation rates. In fact,
the model predicts no BNF biotransformation during the first
5−6 h in cells cotreated with 25 μM of NOC and BNF (Figure
3A). This supports our hypothesis that the presence of 25 μM
NOC delays the elimination of BNF molecules, which means
that more CYP1A enzymes are occupied by BNF after 6 h
compared to cells that have been coexposed with a low
concentration (1 μM) of NOC (Figure 3C). The model
predicts that most of the CYP1A enzymes are being occupied
by NOC molecules in a NOC dose-dependent manner during
the first 6 h (Figure 3D). In accordance, the model predicts
that almost no CYP1A enzymes are occupied by BNF during
the first 6 h in the presence of either 10 or 25 μM NOC. The
time delay for BNF to bind to free CYP1A enzymes is about 5
Figure 3. Model predictions for four state variables. (A) Model predictions of BNF (X) concentrations, (B) model predictions of NOC (Y)
concentrations, (C) model predictions of number of CYP1A enzymes occupied by BNF (EOX), (D) model predictions of number of CYP1A
enzymes occupied by BNF (EOY). The plots depict the model predictions based on the parameters derived from the fit to experimental EROD data
(Table S1) from six different treatment experiments: Treatment (1) 0.1 μM BNF (orange solid line), Treatment (2) 0.1 μM BNF + 1 μM NOC
(brown solid line), Treatment (3) 0.1 μM BNF + 10 μM NOC (pink solid line), Treatment (4) 0.1 μM BNF + 25 μM NOC (blue solid line),
Treatment (5) 1 μM BNF + 1 μM NOC (purple dashed line), and Treatment (6) 1 μM BNF + 25 μM NOC (green dashed line). The model is
described by eqs 4, 5 and 9−13 and the parameters are listed in Table 1. In all treatments, the EROD activities have been measured at five different
time points from 6 to 72 h.21,22
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h shorter for the cells cotreated with 1 μM NOC compared to
cells treated with 25 μM NOC (Figure 3A,C). We conclude
that it is the delayed elimination of BNF by NOC inhibition of
CYP1A enzymes that causes the synergistic mixture effect on
the CYP1A-mediated EROD activity.
3.2. Model Validation. The model was validated with data
from a seventh experiment,21,22 Treatment (7) 1 μM BNF +
10 μM NOC shown in Figure 4, which was not used in the
parameter estimation procedure.

































The model prediction for the EROD activity of free CYP1A
enzymes is in good agreement with the experimental values of
EROD activities from Treatment 7 (Figure 4A). The model
predicts how the numbers of CYP1A enzymes occupied by
BNF and NOC change over time (Figure 4B, bottom panel).
The model also predicts that BNF is not being biotransformed
by CYP1A enzymes during the first 5 h in the presence of 10
μM NOC (Figure 4B, top panel).
The validation test shows that the model has good
prediction power and can be used to test different
combinations of two chemicals and their effect on the
EROD activity of free CYP1A enzymes (Figure 4).
3.3. Global Sensitivity Analysis. The ranges from GSA
for the EROD activity of free CYP1A enzymes are illustrated
using 5−95, 25−75, and 50% (median) quantiles (Figure 5).
The GSA revealed a high sensitivity of the EROD activity of
free CYP1A enzymes in all treatments to changes in the
CYP1A degradation rate (kD). To reduce the uncertainty in the
model predictions, the value of kD should therefore be
estimated with low uncertainty. In addition, the GSA indicated
that changes in the biotransformation rate of BNF (kOX) have
no or insignificant individual effect on the robustness of the
dynamics of free CYP1A enzymes. To rank the kOX as a
noninfluential parameter on the dynamics of free CYP1A
enzymes, further analysis is required to calculate the joint effect
of this parameter because of its interaction with the other
parameters. This can be beneficial for model simplification but
was not the main focus of this study. Hence, the GSA revealed
that kD is an influential parameter. It also confirmed that the
number of free CYP1A enzymes over time is more sensitive to
the changes in the threshold concentration of BNF to induce
EROD activity (cX) compared to the changes in the threshold
concentration of NOC to induce EROD activity (cY) (Figure
5).
3.4. LSA and Practical Identifiability. The first source of
practical nonidentifiability is assessed by computing the
sensitivity values of Ef
EROD using eq 16. The LSA indicated
that the three parameters kD, kX, and kY have the largest
negative average effects on the EROD activity of free CYP1A
enzymes and are followed by cX, cY, and ki, respectively. The
other four parameters on an average have positive effects on
the EROD activity of free enzymes, with kOX being the
parameter with the least effect (Table 2). This is in good
agreement with the results from GSA (Figure 5). The
sensitivity values of the 10 parameters at each time point for
the six treatments are provided in Figure S1.
A parameter with no or insignificant effect on the EROD
activity of free CYP1A enzymes was classified as a practically
nonidentifiable parameter. It has been suggested that the
threshold value classified as a nonidentifiable parameter is 4
orders of magnitude lower than the maximum root-mean-
squared value.31 All of the 10 parameters are above this cutoff
value of 0.012 (Table 2). Hence, all the 10 model parameters
have significant effects on the EROD activity of free CYP1A
Figure 4.Model validation. (A) The model was validated using data from an additional experiment, Treatment (7) 1 μM BNF + 10 μMNOC (red
circles). The model prediction for the EROD activity of free CYP1A enzymes from the model (solid red line) is compared with the experimental
EROD data (pmol·(min·mg protein)−1) (Table S1).21,22 (B) Model predictions of changes in the concentrations of BNF (X) and NOC (Y)
molecules over time (top panel). Model predictions of the changes in the number of CYP1A enzymes occupied by BNF (EOX) and NOC (EOY)
over time (bottom panel). The model is described by eqs 4, 5, and 9−13 and the parameters are listed in Table 1. The experimental data are
provided in Table S1.
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enzymes with the experimental EROD data. This indicates a
strength of the model because the first source of practical
nonidentifiability is not a problem.
The parameters may also interfere with each other. Because
of the interdependence among the parameters, the possible
effect of each parameter on the EROD activity of free CYP1A
enzymes may be compensated by change(s) in other
parameter(s), known as parameter collinearity. A parameter
set with collinearity index above 20 is considered as a
nonidentifiable set.32
The maximum values of collinearity indices for sets
inholding different combinations of the parameters two-ten
were 5.60, 8.06, 9.54, 11.58, 14.43, 15.07, 15.58, 16.50, and
17.39, respectively. The collinearity index for all the 10
parameter combinations is provided in Figure S2. The
collinearity analysis indicated that all sets with different
combinations of parameters had a collinearity index below
20. This led us to conclude that by using the experimental
EROD data, unique values for each of the 10 parameters in the
model can be estimated simultaneously. Moreover, non-
identifiability due to collinearity between parameters is not a
problem.
Azoles have been shown to interact with CYP enzymes,
including CYP1A in fish.13−18 For example, ketoconazole was
Figure 5. GSA: Sensitivity range of the EROD activities22 of free CYP1A enzymes over time to changes in one parameter per row is illustrated. The
sensitivity ranges are depicted by using 5−95% (light blue), 25−75% (dark blue), and 50% (red) quantiles of the EROD activities of free CYP1A
values (vertical axis) estimated by the model on the time interval from dosing (t = 0) to t = 72 h (horizontal axis) for six different treatments:
Treatment (1) 0.1 μM BNF, Treatment (2) 0.1 μM BNF + 1 μM NOC, Treatment (3) 0.1 μM BNF + 10 μM NOC, Treatment 4) 0.1 μM BNF +
25 μM NOC, Treatment (5) 1 μM BNF + 1 μM NOC, and Treatment (6) 1 μM BNF + 25 μM NOC.















msqr are the root-mean-squared sensitivity measures defined in eq 17,
and the mean values are the average of the sensitivity values illustrated
in Figure S1.
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shown to act as a potent noncompetitive inhibitor of
microsomal CYP1A activities in Atlantic cod.18 Coexposure
of ketoconazole that inhibits CYP1A and CYP3A enzymes
resulted in increased sensitivity to ethinylestradiol exposure in
rainbow trout.19 Synergistic effects between antifungal azoles
and insecticides have earlier been reported. Thus, the azole
prochloraz inhibited the biotransformation of a pyrethroid,
resulting in increased insecticide toxicity in honeybees
coexposed to prochloraz.33 The azole-mediated inhibition of
CYP-dependent detoxification of pesticide was suggested being
the main mechanism behind the synergizing effect of azoles on
pesticide toxicity.12 However, the synergistic effect of
antifungal azoles on pyrethroid insecticide toxicity was not
correlated with the azole inhibition strength on the CYP-
mediated ethoxycoumarin-O-deethylase activity in two aquatic
invertebrates, implying that the mechanisms behind the
synergism are more complex.34 There also seem to be species
differences in enzyme susceptibility toward azoles.35 In PLHC-
1 cells, coexposure to the azole NOC delayed the response to
BNF exposures, indicating that NOC prevents biotransforma-
tion of BNF, presumably by inhibition of CYP1A enzymes.21
This suggests a delayed CYP1A-mediated biotransformation of
BNF in the presence of NOC. Delayed biotransformation for
benzo[a]pyrene was demonstrated in two rainbow trout cell
lines (RTL-W1 and RTgutGC) coexposed with the CYP1A
(EROD) inhibitor α- BNF.36 Hence, inhibition of CYP
metabolism can increase the biological half-life of aromatic
hydrocarbons, resulting in increased sensitivity to exposures to
aromatic hydrocarbons.
The synergistic mixture effect with α-cypermethrin and two
azoles in D. magna correlated with the inhibition of the CYP-
mediated EROD activity by prochloraz and to some extent
with the inhibition by propiconazole. It was suggested that a
toxicokinetic and toxicodynamic model could be a tool to test
the mechanisms of interactions between chemicals.12 In the
present study, we also use a toxicokinetic approach focusing on
the inhibition of CYP1A enzyme activity by NOC, by using a
Hill function to model the competition between the azole
NOC and the AhR agonist BNF. The time that these two
chemicals are competing and the steepness of the rate of
biotransformation of BNF depend on the Hill coefficient,
which was fixed at a preselected value to optimize the model fit
to the data. Here, the model might not give a real estimation
on how the biotransformation of BNF is controlled by NOC.
The model can be further refined in future studies by including
chemical data.
The new model presented here successfully predicts the
changes in the EROD activities of free CYP1A enzymes over
time by fitting the model to experimental EROD data with
given mixtures of BNF and NOC. Ten parameters could be
estimated in the model. We hypothesize that the synergistic
effect is a result of NOC-mediated inhibition of the CYP1A-
dependent clearance of BNF. Synergistic mixture effects were
seen with two other azoles, clotrimazole and prochloraz, in
PLHC-1 cells. These azoles also acted as inhibitors of the
EROD activities (having IC50 values below 10 μM). The azole
omeprazole, on the other hand, did not significantly inhibit
EROD activities (having an IC50 value above 50 μM), and
there was no synergistic mixture effect when BNF was mixed
with omeprazole.21 This supports our hypothesis that
inhibition of CYP1A activities triggers a synergistic mixture
effect. A similar synergistic mixture effect on the CYP1A
biomarker has been observed in cells exposed to another AhR
agonist, the polycyclic aromatic hydrocarbon benzo[a]pyrene,
in combination with an antifungal imidazole drug clotrimazole
(Alvord, C.; Lundh, T.; Wiklander, K.; Bernhardsson, A.;
Celander, M.C. data not shown). Hence, the model has a
potential to be used for other chemical mixtures.
Sensitivity and identifiability analysis revealed that the
parameter corresponding to the rate of CYP1A enzyme
degradation is the most influential parameter on the dynamics
of the EROD activity of free CYP1A enzymes predicted by the
model. In contrast, the parameter related to biotransformation
of BNF is the parameter with the least individual influence on
this variable. Hence, to reduce the total uncertainty in the
model predictions for the EROD activity of CYP1A enzymes,
the parameter corresponding to the rate of CYP1A enzyme
degradation should be estimated with low uncertainty. The
present study provides a new promising toxicokinetic model
with predictive power to describe synergistic mixture effects
between aromatic hydrocarbons and azoles.
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Aranguren-Abadiá from the Department of Biosciences at
University of Bergen for helping with preparing the graphics.
■ ABBREVIATIONS
AhR aryl hydrocarbon receptor
BNF β-naphthoflavone
CYP1A cytochrome P450 1A
GSA global sensitivity analysis
EROD ethoxyresorufin-O-deethylase
FME flexible modeling environment
LSA local sensitivity analysis
NOC nocodazole
ODE ordinary differential equation
PLHC-1 Poeciliopsis lucida hepatocellular carcinoma
■ REFERENCES
(1) Hinton, D. E.; Segner, H.; Au, D. W. T.; Kullman, S. W.;
Hardman, R. C. Liver Toxicity. In The Toxicology of Fishes; Di Gulio,
R. T., Hinton, D. E., Eds.; CRS Press. Taylor & Francis Group, 2008,
Chapter 7; pp 328−352.
(2) Fent, K.; Weston, A.; Caminada, D. Ecotoxicology of human
pharmaceuticals. Aquat. Toxicol. 2006, 76, 122−159.
(3) Corcoran, J.; Winter, M. J.; Tyler, C. R. Pharmaceuticals in the
aquatic environment: A critical review of the evidence for health
effects in fish. Crit. Rev. Toxicol. 2010, 40, 287−304.
(4) Celander, M. C. Cocktail effects on biomarker responses in fish.
Aquat. Toxicol. 2011, 105, 72−77.
(5) Groten, J. P.; Feron, V. J.; Sühnel, J. Toxicology of simple and
complex mixtures. Trends Pharmacol. Sci. 2001, 22, 316−322.
(6) Hadrup, N.; Taxvig, C.; Pedersen, M.; Nellemann, C.; Hass, U.;
Vinggaard, A. M. Concentration addition, independent action and
generalized concentration addition models for mixture effect
prediction of sex hormone synthesis in vitro. PLoS One 2013, 8,
No. e70490.
(7) Rajapakse, N.; Silva, E.; Scholze, M.; Kortenkamp, A. Deviation
from additivity with estrogenic mixtures containing 4-nonylphenol
and 4-tert-octylphenol detected in the E-SCREEN assay. Environ. Sci.
Technol. 2004, 38, 6343−6352.
(8) Crofton, K. M.; Craft, E. S.; Hedge, J. M.; Gennings, C.;
Simmons, J. E.; Carchman, R. A.; Carter, W. H., Jr.; DeVito, M. J.
Thyroid-hormone−disrupting chemicals: evidence for dose-depend-
ent additivity or synergism. Environ. Health Perspect. 2005, 113,
1549−1554.
(9) Hass, U.; Scholze, M.; Christiansen, S.; Dalgaard, M.; Vinggaard,
A. M.; Axelstad, M.; Metzdorff, S. B.; Kortenkamp, A. Combined
exposure to anti-androgens exacerbates disruption of sexual differ-
entiation in the rat. Environ. Health Perspect. 2007, 115, 122−128.
(10) Charles, G. D.; Gennings, C.; Tornesi, B.; Kan, H. L.;
Zacharewski, T. R.; Bhaskar Gollapudi, B.; Carney, E. W. Analysis of
the interaction of phytoestrogens and synthetic chemicals: an in vitro/
in vivo comparison. Toxicol. Appl. Pharmacol. 2007, 218, 280−288.
(11) Bobb, S.; Berggren, E.; Kienzler, A.; van der Linden, S.; Wort,
A. Scientific Methodologies for the Assessment of Combined Effects of
Chemicals − A Survey and Literature Review. Use of Novel and
Alternative Methods in the Assessment of Effects from Combined Exposure
to Multiple Chemicals, JRC Technical Reports. EUR 27471 EN, 2015.
(12) Cedergreen, N.; Dalhoff, K.; Li, D.; Gottardi, M.; Kretschmann,
A. C. Can toxicokinetic modeling be used to understand and predict
synergistic interactions between chemicals? Environ. Sci. Technol.
2017, 51, 14379−14389.
(13) Bach, J.; Snegaroff, J. Effects of the fungicide prochloraz on the
xenobiotic metabolism in Rainbow trout − in vivo induction.
Xenobiotica 1989, 19, 1−9.
(14) Levine, S. L.; Czosnyka, H.; Oris, J. T. Effects of the fungicide
clotrimazole on bioconcentration of benzo[a]pyrene in gizzard shad
(Dorosoma cepedianum): In vivo and in vitro inhibition of CYP1A
activity. Environ. Toxicol. Chem. 1997, 16, 306−311.
(15) Egaas, E.; Sandvik, M.; Fjeld, E.; Kal̈lqvist, T.; Goksøyr, A.;
Svensen, A. Some effects of the fungicide propiconazole on
cytochrome P450 and glutathione S-transferase in brown trout
(Salmo trutta). Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol.
Endocrinol. 1999, 122, 337−344.
(16) Sturm, A.; Cravedi, J. P.; Perdu, E.; Baradat, M.; Segner, H.
Effects of prochloraz and nonylphenol diethoxylate on hepatic
biotransformation in trout: A comparative in vitro/in vivo-assessment
using cultured hepatocytes. Aquat. Toxicol. 2001, 53, 229−245.
(17) Hegelund, T.; Ottosson, K.; Rådinger, M.; Tomberg, P.;
Celander, M. C. Effects of ketoconazole on CYP1A and CYP3A in
rainbow trout and killifish. Environ. Toxicol. Chem. 2004, 23, 1326−
1334.
(18) Hasselberg, L.; Grøsvik, B. E.; Goksøyr, A.; Celander, M. C.
Interactions between xenoestrogens and ketoconazole on CYP1A and
CYP3A in juvenile Atlantic cod (Gadus morhua). Comp. Hepatol.
2005, 4, 2.
(19) Hasselberg, L.; Westerberg, S.; Wassmur, B.; Celander, M. C.
Ketoconazole, an antifungal imidazole, increases the sensitivity of
rainbow trout to 17α-ethynylestradiol exposure. Aquat. Toxicol. 2008,
86, 256−264.
(20) Wassmur, B.; Gran̈s, J.; Norström, E.; Wallin, M.; Celander, M.
C. Interactions of pharmaceuticals and other xenobiotics on key
detoxification mechanisms and cytoskeleton in Poeciliopsis lucida
hepatocellular carcinoma, PLHC-1 cell line. Toxicol. In Vitro 2013, 27,
111−120.
(21) Gra ̈ns, J.; Johansson, J.; Michelova,́ M.; Wassmur, B.;
Norström, E.; Wallin, M.; Celander, M. C. Mixture effects between
different azoles and β-naphthoflavone on the CYP1A biomarker in a
fish cell line. Aquat. Toxicol. 2015, 164, 43−51.
(22) Michelova,́ M. Cocktail Effects of β-naphthoflavone and
Nocodazole in the Poeciliopsis lucida Cell Line. Master-thesis,
University of Gothenburg, 2012.
(23) Segner, H. Fish cell lines as a tool in aquatic toxicology. In Fish
Ecotoxicology; Branbeck, T., Hinton, D. E., Streit, B., Eds.; Springer
Basel AG, 1998; Vol. 86; pp 1−38.
(24) Fent, K. Fish cell lines as versatile tools in ecotoxicology:
assessment of cytotoxicity, cytochrome P4501A induction potential
and estrogenic activity of chemicals and environmental samples.
Toxicol. In Vitro 2001, 15, 477−488.
(25) Celander, M.; Bremer, J.; Hahn, M. E.; Stegeman, J. J.
Glucocorticoid-xenobiotic interactions: dexamethasone-mediated po-
tentiation of cytochrome P4501A by ß-naphthoflavone in a fish
hepatoma cell line (PLHC-1). Environ. Toxicol. Chem. 1997, 16, 900−
907.
Environmental Science & Technology pubs.acs.org/est Article
https://dx.doi.org/10.1021/acs.est.0c04839
Environ. Sci. Technol. 2020, 54, 13748−13758
13757
(26) R Core Team. R A language and environment for statistical
computing; R Foundation for Statistical Computing: Vienna, Austria,
2020, URL https://www.R-project.org/.
(27) Tofallis, C. A better measure of relative prediction accuracy for
model selection and model estimation. J. Oper. Res. Soc. 2015, 66,
1352−1362.
(28) Soetaert, K.; Petzoldt, T. Inverse modelling, sensitivity and
monte carlo analysis in R using package FME. J. Stat. Software 2010,
33, 1−28.
(29) Soetaert, K.; Herman, P. M. A Practical Guide to Ecological
Modelling: Using R as a Simulation Platform; Springer Science &
Business Media, 2008.
(30) Soetaert, K. E.; Petzoldt, T.; Setzer, R. W. Solving differential
equations in R: package deSolve. J. Stat. Software 2010, 33, 6−7.
(31) Gab́or, A.; Villaverde, A. F.; Banga, J. R. Parameter
identifiability analysis and visualization in large-scale kinetic models
of biosystems. BMC Syst. Biol. 2017, 11, 1−16.
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